Exposure of Candida to p-anisaldehyde inhibits its growth and ergosterol biosynthesis

Journal of General and Applied Microbiology

Volumn 57, Issue 3, 2011, Pages 129-136

  Shreaz, Sheikh ^a   Bhatia, Rimple ^a   Khan, Neelofar ^a   Muralidhar, Sumathi ^b   Basir, Seemi F ^a   Manzoor, Nikhat ^a   Khan, Luqman Ahmad ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Antifungal activity; Candida; Ergosterol; p anisaldehyde

Indexed keywords

ALCOHOL DEHYDROGENASE; ANISALDEHYDE; ARYL ALCOHOL DEHYDROGENASE; ERGOSTEROL; FLUCONAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANISE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; FUNGICIDAL ACTIVITY; FUNGISTASIS; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MYOBLAST; NONHUMAN; PICHIA GUILLIERMONDII; PLANT SEED; RAT; STEROL SYNTHESIS; TOXICITY TESTING;

ANIMALS; ANTIFUNGAL AGENTS; BENZALDEHYDES; CANDIDA; CELL SURVIVAL; CELLS, CULTURED; ERGOSTEROL; INDIA; MICROBIAL SENSITIVITY TESTS; MYOBLASTS; NADP; PIMPINELLA; PLANT EXTRACTS; RATS;

CANDIDA; PIMPINELLA ANISUM; RATTUS;

EID: 79960888255     PISSN: 00221260     EISSN: 13498037     Source Type: Journal    
DOI: 10.2323/jgam.57.129     Document Type: Article

References (20)

1. Ahmad, A., Khan, A., Manzoor, N., and Khan, L. A. (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb. Pathog., 48, 35-41.
2. Arthington-Skaggs, B. A., Jradi, H., Desai, T., and Morrison, C. J. (1999) Quantification of ergosterol content: Novel method for determination of Fluconazole susceptibility of Candida albicans. J. Clin. Microbiol., 37, 3332-3337.
3. Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., and Monk, B. C. (2009) Efflux-mediated antifungal drug resistance. Clin. Microbiol. Rev., 22, 291-321.
4. Eggimann, P., Garbino, J., and Pittet, D. (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis., 3, 685-702.
5. Fitzgerald, D. J., Stratford, M., Gasson, M. J., and Narbad, A. (2004) The potential application of vanillin in preventing yeast spoilage of soft drinks and fruit juices. J. Food Prot., 67, 391-395.
6. Geber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., and Bennett, J. E. (1995) Deletion of the Candida glabrata ERG3 and ERG11 genes: Effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob. Agents Chemother., 39, 2708-2727.
7. Gupta, M. K., Neelakantan, T. V., Sanghamitra, M., Tyagi, R. K., Dinda, A., Mualik, S., Mukhopadhyay, C. K., and Goswami, S. K. (2006) An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. Antioxid. Redox. Signal., 8, 1081-1093.
8. Hoehamer, C. F., Edwin, D. C., George, M. H., and David Rogers, P. (2010) Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Antimicrob. Agents Chemother., 54, 1655-1664.
9. Kohli, A., Smriti, K., Mukhopadhyay, K., Rattan, A., and Prasad, R. (2002) In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother., 46, 1046-1052.
10. Lopez-Malo, A., Alzamora, S. M., and Argaiz, A. (1995) Effect of natural vanillin on germination time and radial growth of moulds in fruit based agar systems. Food Microbiol., 12, 213-219.
11. Lu, Y., Na, G., Yang, Y., Xiuping, W., Rizeng, M., Junwen, F., Fa, G., Wang, X., Jingbo, L., and Deng, X. (2010) Microarray analysis of p-anisaldehyde-induced transcriptome of Saccharomyces cerevisiae. J. Ind. Microbiol. Biotechnol., 37, 313-322.
12. Odds, F. C., Brown, A. J., and Gow, N. A. (2003) Antifungal agents: Mechanisms of action. Trends Microbiol., 11(6), 272-279.
13. Onyewu, C., Blankenship, J. R., Poeta, M. D., and Heitman, J. (2000) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother., 956-964.
14. Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., and Wenzel, R. P. (1998) National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis., 30, 121-129.
15. Sanglard, D., Ischer, F., Koymans, L., and Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14 alpha-demethylase (CYP51A1) from azole-resistant Candida albicans isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother., 42, 241-253.
16. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., and Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother., 39, 2378-2386.
17. Sheikh, S., Sheikh, R. A., Bhatia, R., Hashmi, A. A., Manzoor, N., and Khan, L. A. (2010) Anticandidal activity of cinnamaldehyde, its ligand and Ni(II) complex: Effect of increase in ring and side chain. Microb. Pathog., 49, 75-82.
18. Vanden, B. H., Marichal, P., and Odds, F. C. (1994) Molecular mechanisms of drug resistance in fungi. Trends Microbiol., 2, 393-400.
19. White, T. C. (1997) The presence of an R467K amino acid substitution and loss of allelic variation correlates with an azole-resistant lanosterol 14 alphade methylase in Candida albicans. Antimicrob. Agents Chemother., 41, 1488-1494.
20. Wingard, J. R., Kubilis, P., Lee, L., Yee, G., White, M., Walshe, L., Bowden, R., Anaissie, E., Hiemenz, J., and Lister, J. (1999) Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin. Infect. Dis., 29, 1402-1407.